AI PRICE FORECAST
UNH Stock Forecast & AI Price Prediction
UnitedHealth Group · Healthcare · Healthcare Plans
UNH live signal snapshot
Shares of UNH were last at $402.94, down 0.54% on the day, trading 12.7% below its 52-week high of $461.62 and 57.4% above its 52-week low of $255.97. The model's verdict for UNH right now: HOLD (72% confidence). The technical signals aren't aligned enough for a directional call yet. The short-term averages are tangled, giving no clean trend signal either way. Its one-month projection is about $412.74, a 2.4% move from the last price.
UNH's 14-day RSI is 37.9 — approaching oversold, suggesting weakening momentum. The MACD indicator trails its signal line, with a histogram of -1.62 pointing to selling pressure. With the 50-day average at $391.19, 7.1% over the 200-day's $365.31, the longer-term trend structure remains positive.
25 Wall Street analysts covering UNH put the average price target at $476.16 (range $380.00–$531.00), implying 18.2% upside from the current price. The current recommendation trend leans bullish: 21 Buy/Strong Buy ratings vs 0 Sell/Strong Sell (and 5 Hold).
Live figures from real market data feeds, current as of the last site build. Open the interactive UNH dashboard for numbers updated throughout today's session.
About UnitedHealth Group
UnitedHealth Group Incorporated (UNH) is a healthcare plans company in the healthcare sector, headquartered in Eden Prairie, MN, United States. UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It has a market value of about $361.0 billion and roughly 390,000 full-time employees. With a beta of 0.52, the stock has historically moved less than the overall market.
UNH performance vs. the market
Year to date, UNH has gained 22.1%, ahead of the S&P 500 (+11.4%) and ahead of the healthcare sector fund XLV (+22.1%). Over the past 12 months the stock has gained 25.3%, 13.8 points better than the S&P 500. Its +6.7% move over the past month extends a +1.0% three-month run.
| Period | UNH | Sector (XLV) | S&P 500 |
|---|---|---|---|
| 1 month | +6.7% | +11.4% | −2.3% |
| 3 months | +1.0% | +12.2% | −2.3% |
| Year to date | +22.1% | +22.1% | +11.4% |
| 1 year | +25.3% | +28.3% | +11.5% |
UnitedHealth Group financials at a glance
UnitedHealth Group's most recent quarter (ended Sep 30, 2026) brought in $112.7 billion of revenue and net income of $4.1 billion (a 3.6% net margin). Revenue was down 0.4% from the same quarter a year earlier. The stock trades at a price-to-earnings ratio of 23.0 on trailing earnings of $17.52 per share. Trailing free cash flow was $26.5 billion, and total debt equals 70% of shareholders' equity.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Sep 30, 2026 | $112.7B | $4.1B |
| Jun 30, 2026 | $112.0B | $5.5B |
| Mar 31, 2026 | $111.7B | $6.3B |
| Dec 31, 2025 | $113.2B | $10M |
UNH vs. its peers
UNH's +22.1% this year ranks ahead of 2 of the 5 big healthcare names below. The strongest of the group this year is Humana (HUM, +74.3%).
| Company | Price | YTD | P/E | AI verdict |
|---|---|---|---|---|
| UnitedHealth Group (UNH) | $402.94 | +22.1% | 23.0 | HOLD |
| CVS Health (CVS) | $89.52 | +12.8% | 10.4 | HOLD |
| Elevance Health (ELV) | $429.48 | +22.5% | 18.2 | HOLD |
| The Cigna Group (CI) | $301.45 | +9.5% | 13.3 | HOLD |
| Humana (HUM) | $446.31 | +74.3% | 43.5 | BUY |
| Eli Lilly and (LLY) | $1,437.29 | +33.7% | 46.7 | BUY |
UNH stock: common questions
What is the UNH stock price target?
25 Wall Street analysts put the average 12-month target at $476.16, in a range of $380.00–$531.00, versus a recent price of $402.94. Stock Pulse 247's model projects about $412.74 over the next month.
Is UNH a buy right now?
Our AI model currently rates UNH a HOLD at 72% confidence. Among analysts, 21 rate it Buy or Strong Buy, 5 Hold and 0 Sell. Neither is personal advice — weigh them with your own research and risk tolerance.
How has UNH stock performed this year?
Year to date, UNH has gained 22.1%, ahead of the S&P 500 (+11.4%) and ahead of the healthcare sector fund XLV (+22.1%). Over the past 12 months the stock has gained 25.3%, 13.8 points better than the S&P 500. Its +6.7% move over the past month extends a +1.0% three-month run.
What is UNH's 52-week high and low?
UNH has traded between $255.97 and $461.62 over the past 52 weeks; at $402.94 it is 12.7% below its 52-week high of $461.62 and 57.4% above its 52-week low of $255.97.
What sector is UNH in, and who are its peers?
UNH is in the healthcare sector (healthcare plans). Its largest peers on Stock Pulse 247 include CVS Health (CVS), Elevance Health (ELV), The Cigna Group (CI), Humana (HUM).
How accurate is the UNH forecast?
It's a model estimate from price history, technical indicators and analyst targets, not a guarantee — no model predicts short-term moves reliably. Use it as one input alongside your own research.
How this works: the forecast combines UNH's price history, momentum indicators (RSI, MACD, moving averages), volatility and analyst targets into one estimate. It's a model, not a guarantee.